KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Gross Profit (2016 - 2025)

AbbVie (ABBV) has disclosed Gross Profit for 14 consecutive years, with $12.1 billion as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 12.7% to $12.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.0 billion through Dec 2025, up 8.94% year-over-year, with the annual reading at $43.0 billion for FY2025, 8.94% up from the prior year.
  • Gross Profit for Q4 2025 was $12.1 billion at AbbVie, up from $10.5 billion in the prior quarter.
  • The five-year high for Gross Profit was $12.1 billion in Q4 2025, with the low at $7.4 billion in Q3 2023.
  • Average Gross Profit over 5 years is $9.8 billion, with a median of $9.9 billion recorded in 2021.
  • The sharpest move saw Gross Profit soared 40.54% in 2021, then decreased 23.98% in 2023.
  • Over 5 years, Gross Profit stood at $10.6 billion in 2021, then rose by 3.64% to $11.0 billion in 2022, then dropped by 21.5% to $8.6 billion in 2023, then rose by 24.53% to $10.7 billion in 2024, then rose by 12.7% to $12.1 billion in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $12.1 billion, $10.5 billion, and $11.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.